Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS) (NCT06675539) | Clinical Trial Compass
RecruitingNot Applicable
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
France545 participantsStarted 2024-11-11
Plain-language summary
The goal of this observational study is to validate the French version of the PAWSS scale in a population of patients with Alcohol Use Disorders. Prediction of Alcohol Withdrawal Severity Scale (PAWSS) has an excellent psychometric characteristics and predictive value of complicated alcohol withdrawal.
The main question it aims to answer is:
Are the psychometric properties of the French version of the PAWSS scale comparable to those of the English version in a population of alcohol use disorders subjects?
AUDs participants are included and followed for three days during their hospitalization, They will performed several scales and surveys (DSM-5 AUD criteria, AUDIT, French version of PAWSS and CIWA-AR).
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female, aged 18 to 60 years
* Subjects with DSM-5 criteria for alcohol use disorders (AUD)
* Subjects hospitalized for scheduled withdrawal or patients developing alcohol withdrawal hospitalized for another reason.
* Subjects who understand French
* Subject affiliated to the French social security system
* Subject having given their written consent to the study
Exclusion Criteria:
* Subjects transferred from other hospitalization services for whom a withdrawal syndrome could have already been treated.
* Subjects scheduled for discharge within 48 hours.
* Subjects with known uncontrolled epilepsy.
* Subjects unable to understand the questionnaire.
* Subjects unable to give consent or not volunteering for the study.
* Subjects under guardianship or curatorship.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Psychometric qualities evaluation of French PAWSS
Timeframe: 3 days
Trial details
NCT IDNCT06675539
SponsorEtablissement Public de Santé Barthélemy Durand